These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7522658)

  • 1. Palliative high-dose octreotide in a case of severe AIDS-related diarrhea.
    Kim-Sing A; Yoshida EM; Whittaker JS
    Ann Pharmacother; 1994 Jun; 28(6):806-7. PubMed ID: 7522658
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide therapy in AIDS-related, refractory diarrhea: results of a multicentre Canadian-European study. Octreotide International Multicentre AIDS-Diarrhea Study.
    Montaner JS; Harris AG
    AIDS; 1995 Feb; 9(2):209-10. PubMed ID: 7718196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of severe AIDS-associated diarrhea with the somatostatin analog octreotide].
    Oehler R; Loos U
    Med Klin (Munich); 1993 Jan; 88(1):45-7. PubMed ID: 8437531
    [No Abstract]   [Full Text] [Related]  

  • 4. Octreotide in palliative medicine.
    Currow DC; Cooney NJ
    Palliat Med; 1994; 8(2):168. PubMed ID: 7521719
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of AIDS-related refractory diarrhoea with octreotide.
    Moroni M; Esposito R; Cernuschi M; Franzetti F; Carosi GP; Fiori GP
    Digestion; 1993; 54 Suppl 1():30-2. PubMed ID: 8395432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide use in AIDS.
    Pon D; Dong BJ
    DICP; 1990 Oct; 24(10):951-2. PubMed ID: 2244409
    [No Abstract]   [Full Text] [Related]  

  • 7. [The usefulness of the somatostatin analog SMS 201-995 in treating Cryptosporidium-induced diarrhea associated with the acquired immunodeficiency syndrome].
    Santos Gil I; Mur Gimeno P; Herreros Fernández M; del Arco Galán C
    Med Clin (Barc); 1990 Dec; 95(20):796. PubMed ID: 2131392
    [No Abstract]   [Full Text] [Related]  

  • 8. Try this drug when AIDS-related diarrhea won't quit.
    RN; 1994 Dec; 57(12):71. PubMed ID: 7817143
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolution of Cryptosporidium infection in an AIDS patient after improvement of nutritional and immune status with octreotide.
    Simon D; Weiss L; Tanowitz HB; Wittner M
    Am J Gastroenterol; 1991 May; 86(5):615-8. PubMed ID: 2028955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide treatment in secretory and cyrptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): clinical evaluation.
    Liberti A; Bisogno A; Izzo E
    J Chemother; 1992 Oct; 4(5):303-5. PubMed ID: 1479420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of octreotide in the management of chronic diarrhoea in AIDS.
    Colebunders R; Sow S; Coulibaly M; Blot K
    AIDS; 1992 May; 6(5):512. PubMed ID: 1616659
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue.
    Kreinik G; Burstein O; Landor M; Bernstein L; Weiss LM; Wittner M
    AIDS; 1991 Jun; 5(6):765-7. PubMed ID: 1883548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide for chronic diarrhoea in AIDS.
    Romeu J; Miro JM; Clotet B
    AIDS; 1992 Sep; 6(9):1046. PubMed ID: 1489416
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of octreotide in the management of chronic diarrhoea in AIDS.
    Romeu J; Miró JM; Sirera G; Mallolas J; Arnal J; Valls ME; Tortosa F; Clotet B; Foz M
    AIDS; 1991 Dec; 5(12):1495-9. PubMed ID: 1814331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
    Simon DM; Cello JP; Valenzuela J; Levy R; Dickerson G; Goodgame R; Brown M; Lyche K; Fessel WJ; Grendell J
    Gastroenterology; 1995 Jun; 108(6):1753-60. PubMed ID: 7768380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of the somatostatin analog SMS 201-995 in the treatment of diarrhea in patients infected with the human immunodeficiency virus].
    Mallolas J; Miró JM; Gatell JM; Moreno A
    Med Clin (Barc); 1990 Apr; 94(13):516. PubMed ID: 2355767
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide (VIP) secretion and refractory diarrhea in patients with AIDS or AIDS-related complex (ARC).
    Manfredi R; Vezzadini P; Fanti MP; Chiodo F
    Scand J Infect Dis; 1994; 26(1):55-7. PubMed ID: 8191241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide therapy for human immunodeficiency virus--associated diarrhea: pitfalls in drug development.
    Kotler DP
    Gastroenterology; 1995 Jun; 108(6):1939-41. PubMed ID: 7768401
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
    Garcia Compean D; Ramos Jimenez J; Guzman de la Garza F; Saenz C; Maldonado H; Barragan RF; Michel H
    AIDS; 1994 Nov; 8(11):1563-7. PubMed ID: 7848592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.
    Füessl HS; Zoller WG; Kochen MM; Bogner JR; Heinrich B; Matuschke A; Goebel FD
    Klin Wochenschr; 1989 Apr; 67(8):452-5. PubMed ID: 2724869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.